Prosecution Insights
Last updated: April 19, 2026

Mbhb - Uw

22 pending office actions • 8 clients

Portfolio Summary

22
Total Pending OAs
7
Final Rejections
15
Non-Final OAs

Client Portfolio (8 clients)

Client (Assignee)Pending OAs
UNIVERSITY OF WASHINGTON 13
UNIVERSITY OF WASHINGTON 3
Seattle Children'S Hospital D/B/A Seattle Children'S Research Institute 1
UNIVERSITY OF WASHINGTON 1
The Regents of the University of California 1
Washington University 1
The Regents of the University of California 1
The University Of Montana 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
18912238 DESIGNED ANTIBODY-BOUND NANOPARTICLES UNIVERSITY OF WASHINGTON BUNNER, BRIDGET E 1647 Final Rejection Oct 10, 2024
18553610 Systems and Methods for Clearing Indwelling Catheters Seattle Children'S Hospital D/B/A Seattle Children'S Research Institute LEVY, BRANDON WILLIAM 3781 Non-Final OA Oct 02, 2023
18549539 DESIGNED CONSTITUTIVELY ACTIVE CYCLIC GMP-AMP SYNTHASE AS A GENETICALLY ENCODED STIMULANT OF INTERFERONS UNIVERSITY OF WASHINGTON SWIFT, CANDICE LEE 1657 Non-Final OA Sep 07, 2023
18459654 Self-Assembling Protein Nanostructures UNIVERSITY OF WASHINGTON PULLIAM, JOSEPH CONSTANTINE 1687 Non-Final OA Sep 01, 2023
18547897 Methods and Devices to Measure Angular Stiffness of Dental and Medical Implants UNIVERSITY OF WASHINGTON YOON, CHANEL J 3791 Non-Final OA Aug 25, 2023
18359154 SELF-ASSSEMBLING NANOSTRUCTURE VACCINES UNIVERSITY OF WASHINGTON GILL, RACHEL B 1671 Final Rejection Jul 26, 2023
18339519 Scaffolding protein functional sites using deep learning UNIVERSITY OF WASHINGTON KAUFMAN, CLAIRE M 1674 Non-Final OA Jun 22, 2023
18319343 Structured Symmetric Cyclic Peptides as Ligands for Metal Organic Frameworks UNIVERSITY OF WASHINGTON FISHER, MELISSA L 1658 Non-Final OA May 17, 2023
18034622 COMPOSITIONS AND METHODS FOR TREATING CELIAC SPRUE DISEASE The Regents of the University of California NOAKES, SUZANNE MARIE 1656 Non-Final OA Apr 28, 2023
18040746 DE NOVO DESIGNED MIXED CHIRALITY PEPTIDE MACROCYCLES WITH INTERNAL SYMMETRY UNIVERSITY OF WASHINGTON REYNOLDS, FRED H 1658 Non-Final OA Feb 06, 2023
18004545 SARS-COV-2 inhibitors Washington University KATAKAM, SUDHAKAR 1658 Non-Final OA Jan 06, 2023
18000004 ANTIBODY-BOUND NANOPARTICLES UNIVERSITY OF WASHINGTON KONOPELSKI SNAVEL, SARA ELIZABETH 1658 Non-Final OA Nov 28, 2022
17760174 POLYPEPTIDES, COMPOSITIONS, AND THEIR USE TO TREAT OR LIMIT DEVELOPMENT OF AN INFECTION UNIVERSITY OF WASHINGTON GILL, RACHEL B 1671 Final Rejection Nov 17, 2022
17938752 De novo designed protein homodimers containing tunable symmetric pockets UNIVERSITY OF WASHINGTON TSAY, MARSHA M 1656 Non-Final OA Oct 07, 2022
17934343 POLYPEPTIDES FOR USE IN SELF-ASSEMBLING PROTEIN NANOSTRUCTURES UNIVERSITY OF WASHINGTON FISCHER, JOSEPH 1658 Non-Final OA Sep 22, 2022
17931704 COMPOSITIONS AND METHODS FOR TREATING CELIAC SPRUE DISEASE The Regents of the University of California PAPCIAK, SHARON M 1657 Final Rejection Sep 13, 2022
17760180 POLYPEPTIDES AND THEIR USE UNIVERSITY OF WASHINGTON BLUMEL, BENJAMIN P 1671 Non-Final OA Aug 04, 2022
17759175 RIGID HELICAL JUNCTIONS FOR MODULAR REPEAT PROTEIN SCULPTING AND METHODS OF USE UNIVERSITY OF WASHINGTON BUNKER, AMY M 1684 Non-Final OA Jul 20, 2022
17813318 MODIFIED CARBAZOLES AS THERAPEUTIC AGENTS The University Of Montana HIRAKIS, SOPHIA P 1623 Final Rejection Jul 18, 2022
17775657 CLOSED-LOOP FEEDBACK FOR ADDITIVE MANUFACTURING SIMULATION UNIVERSITY OF WASHINGTON BUI, ANDREW THANH 3745 Non-Final OA May 10, 2022
17639442 Self-Assembling Protein Nanostructures Displaying Paramyxovirus and/or Pneumovirus F Proteins and Their Use UNIVERSITY OF WASHINGTON CHEN, STACY BROWN 1672 Final Rejection Mar 01, 2022
17434832 Precise Gene Activation Via Novel Designed Proteins Mediating Epigenetic Remodeling UNIVERSITY OF WASHINGTON SPANGLER, JOSEPH RANKIN 1656 Final Rejection Aug 30, 2021

Managing Mbhb - Uw's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month